Who is iCAD?

iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.

How is breast cancer screening and treatment evolving in the era of COVID-19?

In partnership with:

​   

If you were unable to attend our Virtual Roundtable Event, “How is breast cancer screening and treatment evolving in the era of COVID-19”, access the recording below.

​PLAY RECORDING

iCAD’s Response to COVID-19

Read our response to COVID-19 and learn how our portfolio of solutions supporting cancer detection and therapy continue to offer significant benefits to clinicians, patients and the overall healthcare system.

​READ MORE

Recent News

June 1, 2020
iCAD Hosts Virtual Roundtable Event on Breast Cancer Surgery and Targeted Radiation During COVID-19

May 13, 2020
iCAD Presents Positive New Clinical Data for Xoft Brain IORT at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program

May 11, 2020
iCAD Reports First Quarter 2020 Financial Results

May 5, 2020
iCAD to Report First Quarter 2020 Financial Results on Monday, May 11

April 23, 2020
iCAD Announces Pricing of $12.5 Million Registered Direct Offering

April 13, 2020
iCAD Partners with the TME Breast Care Network to Host Virtual Event: Breast Care Roundtable in the Age of COVID-19

CONNECT

© 2018, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.